Tag: GLUE

Monte Rosa Therapeutics has recently announced the commencement of IND enabling studies for MRT-8102, a groundbreaking NEK7-targeted molecular glue degrader ...

On February 15, 2024, Wedbush initiated coverage on Monte Rosa Therapeutics Inc (NASDAQ:GLUE), recognizing the company's groundbreaking potential in the ...